Delivery Order SPE2DB22D2009-SPE2DB25FM0ZY
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Methotrexate 2.5 mg tablets in quantities of 100 units, with a ceiling value of $10,409.17. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order and is scheduled for completion by September 8, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Methotrexate 2.5 mg tablets in quantities of 100 units, with a ceiling value of $2,119.10. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 15,...
- The Defense Logistics Agency awarded a $373,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 100 units of 2.5 mg methotrexate tablets. As one of the largest pharmaceutical distributors supporting the Department of Defense supply chain, Amerisourcebergen will deliver the pharmaceutical products from its facility in Conshohocken, Pennsylvania by July 20, 2023 to fulfill DLA requirements. The delivery order was issued under an existing DLA-wide supply...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,951.56 Firm Fixed Price Delivery Order covers the supply of 4,565,087,756 units of Methotrexate 2.5 mg Tablets in 100-count bottles, with a completion date of July 9, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical, which serves as the primary vehicle...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,820.90, is for the delivery of 4560843534 - METHOTREXATE 2.5 MG TABLET 100S. It is a firm fixed price, delivery order contract with a completion date of May 8, 2023. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,500.64, is for the delivery of Methotrexate 2.5 mg tablets (100 count) to support military healthcare programs. The contract is a Delivery Order with a Firm Fixed Price pricing type and has a completion date of May 22, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $1,596.76 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Trexall 10 mg tablets in a 30-count package. This non-set-aside, competitively awarded contract is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Methotrexate 2.5 mg tablets. The $4,588.56 firm fixed-price delivery order has a completion date of December 29, 2023. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC serves as the primary vehicle...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $40,900 firm fixed price delivery order by the Defense Logistics Agency to provide 4562172665 units of methotrexate 50 mg/2 ml vials. The single day contract has a period of performance from September 14 to 15, 2023, with all work to be conducted by Amerisourcebergen at its facility in Conshohocken, Pennsylvania. As the Defense Logistics Agency is responsible for worldwide logistics support of...
- The Defense Logistics Agency Troop Support Medical awarded a $18,880 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561323709 methotrexate 50 mg/2 ml vials. The delivery order was issued against an indefinite-delivery/indefinite-quantity contract vehicle and calls for the delivery of 2 ml vials of methotrexate to a facility in Conshohocken, Pennsylvania. The period of performance is June 23, 2023 through June 26, 2023. No subcontractors or set aside...
- SPE2DB22D2009Indefinite Delivery Contract
- SPE2DB22D2009-SPE2DB25FM0ZYDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,402.77 to AmerisourceBergen Drug Corp for the supply of Methotrexate 2.5 mg tablets in unit dose packaging of 20s. This firm fixed price delivery order, issued on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a non-set-aside competitive award executed under AmerisourceBergen's existing pharmaceutical supply contract vehicle. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military and federal healthcare systems globally. AmerisourceBergen's federal contract portfolio demonstrates its capability as a critical pharmaceutical distributor serving the Defense Health Agency and other government healthcare entities through competitively awarded contracts with firm fixed pricing structures across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 8/19/25 |